Chemokine receptor binding heterocyclic compounds

Compounds which modulate chemokine receptor activities are disclosed. These compounds are preferably tertiary amines comprising tetrahydroquinoline and benzimidazole.

Saved in:
Bibliographic Details
Main Authors TREVOR R. WILSON, MARIA ROSARIAFLURI, DONINIQUE SCHOLS, BERN ATSMA, CURTIS HARWIG, GARY BRIDGER, AL KALLER, YUANXI ZHOU, CHRISTOPHER DENNIS SMITH, RENATO SKERLJ, SIQIAO NAN, ERNEST J. MCEACHERN, DAVID BOGUCKI, JASON CRAWFORD
Format Patent
LanguageEnglish
Published 21.05.2004
Edition7
Subjects
CHEMISTRY
GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINSTCLIMATE CHANGE
Online AccessGet full text

Cover

More Information
Summary:Compounds which modulate chemokine receptor activities are disclosed. These compounds are preferably tertiary amines comprising tetrahydroquinoline and benzimidazole.
Bibliography:Application Number: ZA20030001398